Breaking News

PAREXEL Academy Expands in Singapore with NSU

Program designed to help meet demand for talent in the Asia region

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PAREXEL Academy, a provider of education and professional training in the field of clinical research, has entered into an agreement with the National University of Singapore (NUS), through its National University of Singapore Academy of GxP Excellence (NUSAGE), to offer an academic program in Singapore to help meet the increasing demand for talent in the field of clinical research in the region. PAREXEL Academy is owned and operated by PAREXEL International.
 
According to Dr. Albert Siu, vice president, Learning and Development, PAREXEL International, “The Academy’s location in Singapore provides students with access to a significant business center for the Asia/Pacific region, and supports regional growth in the clinical development field. These graduates will be empowered with the proper education to make a difference in the delivery of innovative new treatments to patients.”
 
“NUSAGE is pleased to partner with PAREXEL in this timely initiative to equip clinical development professionals with critical skills to effectively and efficiently translate research from the lab into clinical studies, and ultimately to bring significant life-saving treatments to patients in Asia and around the world,” said associate professor Chan Sui Yung, head of the department of Pharmacy, NUS.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters